Jiangsu Favored Nanotechnology Inkomsten in het verleden
Verleden criteriumcontroles 1/6
Jiangsu Favored Nanotechnology's earnings have been declining at an average annual rate of -50.3%, while the Chemicals industry saw earnings growing at 4.9% annually. Revenues have been growing at an average rate of 9.2% per year. Jiangsu Favored Nanotechnology's return on equity is 1%, and it has net margins of 4.3%.
Belangrijke informatie
-50.3%
Groei van de winst
-119.0%
Groei van de winst per aandeel
| Chemicals Groei van de industrie | 12.1% |
| Inkomstengroei | 9.2% |
| Rendement op eigen vermogen | 1.0% |
| Nettomarge | 4.3% |
| Laatste winstupdate | 30 Sep 2024 |
Recente prestatie-updates uit het verleden
Recent updates
Opbrengsten en kosten
Hoe Jiangsu Favored Nanotechnology geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.
Inkomsten en omzetgeschiedenis
| Datum | Inkomsten | Inkomsten | G+A Uitgaven | R&D-uitgaven |
|---|---|---|---|---|
| 30 Sep 24 | 443 | 19 | 132 | 87 |
| 30 Jun 24 | 403 | -5 | 149 | 85 |
| 31 Mar 24 | 344 | -26 | 153 | 89 |
| 31 Dec 23 | 309 | -42 | 154 | 86 |
| 30 Sep 23 | 317 | -18 | 144 | 78 |
| 30 Jun 23 | 328 | 7 | 143 | 69 |
| 31 Mar 23 | 357 | 15 | 145 | 57 |
| 31 Dec 22 | 396 | 33 | 150 | 51 |
| 30 Sep 22 | 470 | 42 | 148 | 46 |
| 30 Jun 22 | 478 | 43 | 140 | 44 |
| 31 Mar 22 | 445 | 42 | 135 | 43 |
| 31 Dec 21 | 410 | 39 | 129 | 40 |
| 31 Dec 20 | 238 | 56 | 68 | 37 |
| 31 Dec 19 | 143 | 32 | 52 | 17 |
| 31 Dec 18 | 70 | 15 | 19 | 9 |
Kwaliteitswinsten: 688371 has a high level of non-cash earnings.
Groeiende winstmarge: 688371 became profitable in the past.
Analyse vrije kasstroom versus winst
Analyse van de winstgroei in het verleden
Winsttrend: 688371's earnings have declined by 50.3% per year over the past 5 years.
Versnelling van de groei: 688371 has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Winst versus industrie: 688371 has become profitable in the last year, making it difficult to compare its past year earnings growth to the Chemicals industry (-3.8%).
Rendement op eigen vermogen
Hoge ROE: 688371's Return on Equity (1%) is considered low.